These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Hnasko R; Lisanti MP Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453 [TBL] [Abstract][Full Text] [Related]
5. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Zhao YY; Liu Y; Stan RV; Fan L; Gu Y; Dalton N; Chu PH; Peterson K; Ross J; Chien KR Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11375-80. PubMed ID: 12177436 [TBL] [Abstract][Full Text] [Related]
6. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923 [TBL] [Abstract][Full Text] [Related]
7. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. De Souza AP; Cohen AW; Park DS; Woodman SE; Tang B; Gutstein DE; Factor SM; Tanowitz HB; Lisanti MP; Jelicks LA Magn Reson Imaging; 2005 Jan; 23(1):61-8. PubMed ID: 15733789 [TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Cohen AW; Park DS; Woodman SE; Williams TM; Chandra M; Shirani J; Pereira de Souza A; Kitsis RN; Russell RG; Weiss LM; Tang B; Jelicks LA; Factor SM; Shtutin V; Tanowitz HB; Lisanti MP Am J Physiol Cell Physiol; 2003 Feb; 284(2):C457-74. PubMed ID: 12388077 [TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209 [TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM. Krasteva G; Pfeil U; Drab M; Kummer W; König P Respir Res; 2006 Aug; 7(1):108. PubMed ID: 16904002 [TBL] [Abstract][Full Text] [Related]
13. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Drab M; Verkade P; Elger M; Kasper M; Lohn M; Lauterbach B; Menne J; Lindschau C; Mende F; Luft FC; Schedl A; Haller H; Kurzchalia TV Science; 2001 Sep; 293(5539):2449-52. PubMed ID: 11498544 [TBL] [Abstract][Full Text] [Related]
14. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204 [TBL] [Abstract][Full Text] [Related]
16. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. Woodman SE; Park DS; Cohen AW; Cheung MW; Chandra M; Shirani J; Tang B; Jelicks LA; Kitsis RN; Christ GJ; Factor SM; Tanowitz HB; Lisanti MP J Biol Chem; 2002 Oct; 277(41):38988-97. PubMed ID: 12138167 [TBL] [Abstract][Full Text] [Related]
18. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Razani B; Combs TP; Wang XB; Frank PG; Park DS; Russell RG; Li M; Tang B; Jelicks LA; Scherer PE; Lisanti MP J Biol Chem; 2002 Mar; 277(10):8635-47. PubMed ID: 11739396 [TBL] [Abstract][Full Text] [Related]
19. Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation. Yang G; Timme TL; Naruishi K; Fujita T; Fattah el MA; Cao G; Rajagopalan K; Troung LD; Thompson TC Exp Mol Pathol; 2008 Apr; 84(2):131-40. PubMed ID: 18358473 [TBL] [Abstract][Full Text] [Related]
20. Evolutionary analysis and molecular dissection of caveola biogenesis. Kirkham M; Nixon SJ; Howes MT; Abi-Rached L; Wakeham DE; Hanzal-Bayer M; Ferguson C; Hill MM; Fernandez-Rojo M; Brown DA; Hancock JF; Brodsky FM; Parton RG J Cell Sci; 2008 Jun; 121(Pt 12):2075-86. PubMed ID: 18505796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]